5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.66▲ | 1.65▲ | 1.67▲ | 1.59▲ | 1.51▲ |
MA10 | 1.66▲ | 1.68▲ | 1.71▲ | 1.50▲ | 1.44▲ |
MA20 | 1.71▲ | 1.70▲ | 1.66▲ | 1.45▲ | 1.35▲ |
MA50 | 1.69▲ | 1.55▲ | 1.50▲ | 1.43▲ | N/A |
MA100 | 1.57▲ | 1.50▲ | 1.50▲ | 1.28▲ | N/A |
MA200 | 1.51▲ | 1.46▲ | 1.44▲ | 2.17▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.016▼ | -0.011▼ | 0.036▲ | 0.253▲ |
RSI | 55.014▲ | 58.514▲ | 60.802▲ | 63.842▲ | 39.067▼ |
STOCH | 37.732 | 16.092▼ | 20.325 | 56.725 | 45.788 |
WILL %R | -27.586 | -43.243 | -42.105 | -14.815▲ | -66.050 |
CCI | 78.771 | 7.116 | 7.138 | 161.335▲ | 50.624 |
CDL | $JUNS Dark Cloud Cover Candlestick Pattern Detected | Set Alert |
Monday, September 15, 2025 12:00 AM
Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.
|
Tuesday, August 26, 2025 01:00 AM
Jupiter, Florida, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company pioneering therapies for central ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 1.82 | 1.84 | 1.56 | 1.76 | 246,700 |
29/09/25 | 1.6515 | 1.80 | 1.61 | 1.80 | 334,071 |
26/09/25 | 1.38 | 1.67 | 1.38 | 1.59 | 481,400 |
25/09/25 | 1.42 | 1.4295 | 1.36 | 1.40 | 51,222 |
24/09/25 | 1.33 | 1.42 | 1.33 | 1.40 | 66,303 |
23/09/25 | 1.36 | 1.48 | 1.32 | 1.35 | 164,500 |
22/09/25 | 1.43 | 1.4527 | 1.30 | 1.32 | 130,790 |
19/09/25 | 1.41 | 1.52 | 1.41 | 1.43 | 436,000 |
18/09/25 | 1.49 | 1.56 | 1.40 | 1.43 | 133,100 |
17/09/25 | 1.49 | 1.55 | 1.47 | 1.49 | 93,726 |
|
|
||||
|
|
||||
|
|